International Cannabis Weekly: 373

DEA CANNABIS RESCHEDULING HEARING DELAYED UNTIL 2025, AGENCY JUDGE RULES

Chief Administrative Law Judge (ALJ) has issued a preliminary order signalling that the information provided on those set to testify was insufficient and requesting additional details and potential availability for a formal hearing in January or February 2025.

READ MORE  »

JUDGE SAYS NEW YORK’S CRACKDOWN ON UNLICENSED STORE IS UNCONSTITUTIONAL

READ MORE »

PILOT PROJECT IN FRANKFURT COULD SEE THC PRODUCTS SOLD LEGALLY

READ MORE »

• European medical cannabis boom driven by telemedicine and regulatory reforms, new report is set to reveal.
• 118% surge in UK medical cannabis prescriptions, but awareness among professionals and public lags behind.
• For the third time, the Italian administrative court suspends the decree that classified CBD as a narcotic.
• Ireland’s cannabis reform: Oireachtas committee pushes decriminalisation of cannabis in Ireland.
• UK backs a proposition to raise the THC limit in hemp to 0.3%, aligning with EU and U.S. standards.
• Bedrocan expands into Denmark with plans to commercialise a new high-CBD strain of medical cannabis.

DOWNLOAD FREE EXEC SUMMARY »

• New York’s legal cannabis market is now ‘ready to hit its stride’ following a turbulent start.
• DEA cannabis rescheduling hearing delayed until next year, agency judge rules.
• The majority of U.S. cannabis users favour Kamala Harris over Trump, despite both supporting legalisation.
• A new Kansas poll finds a majority of residents favour both medical and adult-use cannabis legalisation.
• South Dakota medical cannabis industry calls for rule changes as patient enrolments continue to decline.
• Adults over the age of 21 can purchase cannabis and have it delivered to the door as of today in Arizona.

• Canadian cannabis market shows ‘chilling’ stagnation with almost zero growth in consumer sales so far in 2024.
• Ontario is stepping up its crackdown on illicit cannabis with a CA$31 million investment over the next three years.
• New Brunswick sees a rise in popularity of ‘convenient’ cannabis products as market continues its shift.
• GCAC forms a new collaboration to deliver enhanced cannabis care for 1,000 Canadian veterans.
• Decibel acquires AgMedica, announces proposed private placement and a positive Q3 2024 outlook.
• Ayurcann post record gross revenue for fiscal year 2024, surpassing CA$45 million.

• Costa Rica’s Ministry of Agriculture and Livestock (MAG) grants 57 hemp production licences.
• Brazil’s Cannabis Federation criticises Sindusfarma’s proposal to restrict medical cannabis imports into Brazil.

• Thai cabinet approves Ministry of Public Health bill to clarify commercial cannabis and hemp regulations.
• Australian companies are becoming frustrated with the country’s reliance on cannabis imports from Canada.
• New Zealand’s Puro partners with Māori group to boost medical cannabis production and provide employment.
• The Legalise Cannabis Party has achieved one of its best results in Queensland’s state election.

• Morocco’s cannabis industry grows as ‘green gold’ sparks new economic opportunities for the country.
• South African company Nexus launches a major project to process and export cannabis grown in the country.